Page 1 of Clinical Trials for Drug Increase response to interferon alpha plus ribavirin by increasing insulin sensitivity, 1 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Suspended
Retreatment of Chronic Hepatitis C Non-Responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone
Last Updated: April 10, 2008
Condition(s): Chronic Hepatitis C

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Increase+response+to+interferon+alpha+plus+ribavirin+by+increasing+insulin+sensitivity

CR Health Net sites have been providing trustworthy health information since 2002.

Follow @medfeeds on Twitter

Browse
Clinical Trials Background
- Clinical Trials FAQ
- Clinical Trials Glossary
About
- About and Contact
- RSS Help

This clinical trials RSS facility is brought to you as a free service by Clinical Trials Feeds (ClinicalTrialsFeeds.org), using data supplied by the US National Institutes of Health and ClinicalTrials.gov. You can also check the CR Health Net site RxDrugLabels.com for an easy-to-use database of the latest product labels and prescription medication package inserts from the US Food and Drug Administration.

Page 1 of Clinical Trials for Drug Increase response to interferon alpha plus ribavirin by increasing insulin sensitivity, 1 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About